ArticleThe Journal of biological chemistry2012

HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors.

Atsuko Hachiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.